Searches , social queries for PARTIAL AGONIST

Search references for PARTIAL AGONIST. Phrases containing PARTIAL AGONIST

See searches and references containing PARTIAL AGONIST!

Searches containing PARTIAL AGONIST

PARTIAL AGONIST

  • Partial agonist
  • Agonist drug having partial efficacy at a receptor

    pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist. They

    Partial agonist

    Partial agonist

    Partial_agonist

  • Agonist
  • Chemical which binds to and activates a biochemical receptor

    agonist for the target receptor. It might be argued that the endogenous agonist is simply a partial agonist in that tissue. An irreversible agonist is

    Agonist

    Agonist

    Agonist

  • Dopamine agonist
  • Compound that activates dopamine receptors

    ergoline agonists are cabergoline and bromocriptine and examples of non-ergoline agonists are pramipexole, ropinirole and rotigotine. Ergoline agonists have

    Dopamine agonist

    Dopamine agonist

    Dopamine_agonist

  • Agonist-antagonist
  • Type of drug

    it occupies a small proportion of receptors. On the other hand, a partial agonist does not have the ability to fully activate the receptors to where

    Agonist-antagonist

    Agonist-antagonist

    Agonist-antagonist

  • Buprenorphine
  • Opioid used to treat pain and opioid use disorder

    are Schedule III controlled substances. Buprenorphine acts as an agonist, partial agonist, or antagonist at different opioid receptors. It relieves opioid

    Buprenorphine

    Buprenorphine

    Buprenorphine

  • Serotonin receptor agonist
  • Neurotransmission-modulating substance

    are 5-HT1A receptor partial agonists. Flibanserin, a drug used for female sexual dysfunction, is a 5-HT1A receptor partial agonist. Many atypical antipsychotics

    Serotonin receptor agonist

    Serotonin receptor agonist

    Serotonin_receptor_agonist

  • Aripiprazole
  • Atypical antipsychotic medication

    whose principal pharmacological action is as a functionally selective partial agonist at dopamine D2 receptors, stabilizing dopamine activity by enhancing

    Aripiprazole

    Aripiprazole

    Aripiprazole

  • List of investigational antipsychotics
  • Investigational antipsychotics

    Brilaroxazine (RP-5000; RP-5063; oxaripiprazole) – dopamine D2 receptor partial agonist, serotonin 5-HT2A receptor antagonist, and other actions – schizophrenia

    List of investigational antipsychotics

    List_of_investigational_antipsychotics

  • RO5203648
  • Pharmaceutical compound

    trace amine-associated receptor 1 (TAAR1) partial agonist. It is a potent and highly selective partial agonist of both rodent and primate TAAR1. The drug

    RO5203648

    RO5203648

    RO5203648

  • TAAR1
  • Protein found in humans

    TAAR1 full agonist RO5256390, the TAAR1 partial agonist RO5263397, and the TAAR1 antagonists EPPTB and RTI-7470-44. Selective TAAR1 agonists are used in

    TAAR1

    TAAR1

    TAAR1

  • Opioid
  • Class of analgesic drug

    Dezocine—agonist/antagonist Pentazocine—agonist/antagonist Phenazocine Buprenorphine—partial agonist Dihydroetorphine Etorphine Butorphanol—agonist/antagonist

    Opioid

    Opioid

    Opioid

  • Receptor antagonist
  • Type of receptor ligand or drug that blocks a biological response

    bound, however, antagonists inhibit the function of agonists, inverse agonists, and partial agonists. In functional antagonist assays, a dose-response curve

    Receptor antagonist

    Receptor antagonist

    Receptor_antagonist

  • Alpha-adrenergic agonist
  • Class of drugs

    partial α1 agonist and light-controlled mydriatic) Methoxamine Midodrine Metaraminol Phenylephrine Amidephrine Sdz-nvi-085 [104195-17-7]. α2 agonist:

    Alpha-adrenergic agonist

    Alpha-adrenergic agonist

    Alpha-adrenergic_agonist

  • GABAA receptor agonist
  • Hallucinogenic drug

    A GABAA receptor agonist is a drug that acts as an orthosteric agonist of the GABAA receptor, the major signaling receptor of the inhibitory neurotransmitter

    GABAA receptor agonist

    GABAA receptor agonist

    GABAA_receptor_agonist

  • Cariprazine
  • Atypical antipsychotic medicine

    primarily as a D3 and D2 receptor partial agonist, with a preference for the D3 receptor. It is a partial agonist at the serotonin 5-HT1A receptor and

    Cariprazine

    Cariprazine

    Cariprazine

  • Motivation-enhancing drug
  • Drug increasing motivation in humans

    (NRIs), and antipsychotics (which are dopamine receptor antagonists or partial agonists). Cannabinoids, for instance those found in cannabis, have also been

    Motivation-enhancing drug

    Motivation-enhancing drug

    Motivation-enhancing_drug

  • Inverse agonist
  • Agent in biochemistry

    inverse agonist is a drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist. A neutral

    Inverse agonist

    Inverse agonist

    Inverse_agonist

  • Opioid antagonist
  • Receptor antagonist that acts on one or more of the opioid receptors

    used, opioid full agonists, these drugs are generally considered to be antagonists for practical purposes. The weak partial agonist effect can be useful

    Opioid antagonist

    Opioid antagonist

    Opioid_antagonist

  • List of investigational autism and pervasive developmental disorder drugs
  • Investigational pervasive developmental disorder drugs

    Brexpiprazole (Rexulti) – dopamine D2 and D3 receptor partial agonist, serotonin 5-HT1A receptor partial agonist, serotonin 5-HT2A 5-HT2B, and 5-HT7 receptor antagonist

    List of investigational autism and pervasive developmental disorder drugs

    List_of_investigational_autism_and_pervasive_developmental_disorder_drugs

  • Alpha-7 nicotinic receptor
  • Type of cell receptor found in humans

    711: partial agonist Tilorone Tropisetron: subtype-selective partial agonist; 5-HT3 receptor antagonist WAY-317,538 — selective potent full agonist with

    Alpha-7 nicotinic receptor

    Alpha-7 nicotinic receptor

    Alpha-7_nicotinic_receptor

  • Bretazenil
  • Chemical compound

    to benzodiazepine binding sites where it acts as a partial agonist. Its profile as a partial agonist and preclinical trial data suggests that it may have

    Bretazenil

    Bretazenil

    Bretazenil

  • SR-17018
  • Atypical opioid drug

    receptor modulator with unusual actions and effects. It acts as a biased partial agonist of the μ-opioid receptor (MOR), showing strong selectivity for activation

    SR-17018

    SR-17018

    SR-17018

  • Intrinsic activity
  • Measure of relative response to a drug

    described as high efficacy partial agonists, as a partial agonist with efficacy over ≈80-90% is indistinguishable from a full agonist in most assays. Similarly

    Intrinsic activity

    Intrinsic activity

    Intrinsic_activity

  • List of investigational antidepressants
  • List of pharmaceutical drugs under clinical development for treatment of depression

    (Cyclurad; NRX-101) – ionotropic glutamate NMDA receptor glycine site partial agonist and atypical antipsychotic (non-selective monoamine receptor modulator)

    List of investigational antidepressants

    List_of_investigational_antidepressants

  • RO5256390
  • Chemical compound

    agonist for the trace amine associated receptor 1 (TAAR1). It is a full agonist of the rat, cynomolgus monkey, and human TAAR1, but a partial agonist

    RO5256390

    RO5256390

    RO5256390

  • Nicotinic agonist
  • Drug that binds to and activates nicotinic acetylcholine receptors

    A nicotinic agonist is a drug that mimics the action of acetylcholine (ACh) at nicotinic acetylcholine receptors (nAChRs). The nAChR is named for its

    Nicotinic agonist

    Nicotinic_agonist

  • Receptor modulator
  • Substance that binds to and regulates the activity of chemical receptors

    modulators are categorized in the Agonist, Partial Agonist, Selective Tissue Modulators, Antagonist, and Inverse Agonist categories in terms of the effect

    Receptor modulator

    Receptor_modulator

  • Varenicline
  • Nicotinic receptor agonist

    treatment of dry eye syndrome. It is a nicotinic acetylcholine receptor partial agonist. When activated, this receptor leads to the release of dopamine in

    Varenicline

    Varenicline

    Varenicline

  • Mu-opioid receptor
  • Class of opioid receptors found in humans

    (or antagonist) Oliceridine Pentazocine (or antagonist) Tramadol (or partial agonist) 7-Hydroxymitragynine MEB-1170 Oliceridine (TRV130) PZM21 SHR9352 SR-15099

    Mu-opioid receptor

    Mu-opioid receptor

    Mu-opioid_receptor

  • List of investigational generalized anxiety disorder drugs
  • Investigational generalized anxiety disorder drugs

    partial agonist [5] Ulotaront (SEP-363856; SEP-856) – trace amine-associated receptor 1 (TAAR1) agonist and serotonin 5-HT1A receptor partial agonist

    List of investigational generalized anxiety disorder drugs

    List_of_investigational_generalized_anxiety_disorder_drugs

  • 5-HT2A receptor
  • Subtype of serotonin receptor

    receptors, and Z3517967757. Quipazine – 5-HT2A agonist but also potent 5-HT3 agonist. SN-22 – partial agonist at all three 5-HT2 subtypes Some benzazepines

    5-HT2A receptor

    5-HT2A receptor

    5-HT2A_receptor

  • Κ-Opioid receptor agonist
  • Drug class

    A κ-opioid receptor agonist, or simply KOR agonist or kappa agonist, is a drug which acts as an agonist of the κ-opioid receptor (KOR), the target of

    Κ-Opioid receptor agonist

    Κ-Opioid receptor agonist

    Κ-Opioid_receptor_agonist

  • 4-PIOL
  • Pharmaceutical compound

    high-efficacy partial agonist in some systems. It does not appear to desensitize GABAA receptors, which is in contrast to higher-efficacy agonists. This property

    4-PIOL

    4-PIOL

    4-PIOL

  • List of investigational anxiety disorder drugs
  • Investigational anxiety disorder drugs

    serotonin 5-HT1A receptor partial agonist and other actions [25] BW-723C86 – serotonin 5-HT2B and 5-HT2C receptor agonist [26] Cannabidiol dry powder

    List of investigational anxiety disorder drugs

    List_of_investigational_anxiety_disorder_drugs

  • NMDA receptor
  • Glutamate receptor and ion channel protein found in nerve cells

    weak partial agonists Homoquinolinic acid – synthetic glutamate site partial agonist N-Methyl-D-aspartic acid (NMDA) – synthetic glutamate site partial agonist

    NMDA receptor

    NMDA receptor

    NMDA_receptor

  • Dopamine receptor D2
  • Main receptor for most antipsychotic drugs

    a partial agonist and potentiates dopamine-mediated prolactin secretion in lactotrophs. LSD is also a 5-HT2A agonist. OSU-6162 – also 5-HT2A partial agonist

    Dopamine receptor D2

    Dopamine receptor D2

    Dopamine_receptor_D2

  • AQW-051
  • Nicotinic agonist medication

    AQW-051 also known as VQW-765 is an orally available, highly selective partial agonist of the alpha-7 nicotinic receptor (nAChR) developed by Novartis as

    AQW-051

    AQW-051

    AQW-051

  • MRK-409
  • Abandoned drug

    MRK-409, also known as MK-0343, is a GABAA receptor partial agonist. It was designed to be a non-sedative anxiolytic, however its development was halted

    MRK-409

    MRK-409

    MRK-409

  • Beta1-adrenergic agonist
  • Examples include: Denopamine (selective β1 agonist) Dobutamine (β1>β2 agonist) Xamoterol (β1 partial agonist) Epinephrine (non-selective) Norepinephrine

    Beta1-adrenergic agonist

    Beta1-adrenergic_agonist

  • 5-HT receptor
  • Class of transmembrane proteins

    Farnsworth NR (August 2005). "Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro". Brain Research. Molecular Brain Research

    5-HT receptor

    5-HT receptor

    5-HT_receptor

  • Cannabinoid
  • Compounds found in cannabis

    (CBN) is a mildly psychoactive cannabinoid acting as a low-affinity partial agonist at CB1 and CB2 receptors. CBN interacts with other neurotransmitter

    Cannabinoid

    Cannabinoid

    Cannabinoid

  • GABA receptor agonist
  • Category of drug

    A GABA receptor agonist is a drug that is an agonist for one or more of the GABA receptors, producing typically sedative effects, and may also cause other

    GABA receptor agonist

    GABA receptor agonist

    GABA_receptor_agonist

  • List of investigational substance-related disorder drugs
  • Investigational substance-related disorder drugs

    dopamine D3 receptor partial agonist – smoking withdrawal Brenipatide (LY-3537031) – glucagon-like peptide-1 (GLP-1) receptor agonist, gastric inhibitory

    List of investigational substance-related disorder drugs

    List_of_investigational_substance-related_disorder_drugs

  • Analgesic
  • Drugs used to achieve relief from pain

    a partial agonist of the μ-opioid receptor, and tramadol is a serotonin–norepinephrine reuptake inhibitor (SNRI) with weak μ-opioid receptor agonist properties

    Analgesic

    Analgesic

    Analgesic

  • IC50
  • Half maximal inhibitory concentration

    higher concentration of inhibitor leads to lowered agonist activity. IC50 value increases as agonist concentration increases. Furthermore, depending on

    IC50

    IC50

    IC50

  • List of antidepressants
  • (Exxua) – 5-HT1A receptor partial agonist and α2-adrenergic receptor antagonist Opipramol (Insidon) — σ1 receptor agonist, other actions Tianeptine (Stablon

    List of antidepressants

    List_of_antidepressants

  • Imidazopyridine
  • Class of compounds

    anxiolytic. It is not used clinically. TP-003—a subtype-selective partial agonist at GABAA receptors, binding to GABAA receptor complexes bearing either

    Imidazopyridine

    Imidazopyridine

    Imidazopyridine

  • Drug antagonism
  • Medicine preventing a biological response

    smooth muscle contraction. In the presence of a full agonist exerting its maximal effect, a partial agonist can behave like a competitive antagonist to lower

    Drug antagonism

    Drug_antagonism

  • Nalbuphine
  • Opioid analgesic

    doses. Nalbuphine is a mixed agonist/antagonist opioid modulator. Specifically, it acts as a moderate-efficacy partial agonist or antagonist of the μ-opioid

    Nalbuphine

    Nalbuphine

    Nalbuphine

  • RO5073012
  • Pharmaceutical compound

    low-efficacy partial agonist of the trace amine-associated receptor 1 (TAAR1) which has been used in scientific research. TAAR1 partial agonists like RO5073012

    RO5073012

    RO5073012

    RO5073012

  • 7-Hydroxymitragynine
  • Atypical opioid analgesic

    μ-opioid receptors (MOR) than mitragynine. It acts primarily as a partial agonist at μ-opioid receptors while antagonizing δ- and κ-opioid receptors;

    7-Hydroxymitragynine

    7-Hydroxymitragynine

    7-Hydroxymitragynine

  • Cannabinoid receptor 2
  • Mammalian protein found in humans

    ligand-induced receptor desensitization and downregulation following repeated agonist application, perhaps causing the receptor to become less responsive to

    Cannabinoid receptor 2

    Cannabinoid receptor 2

    Cannabinoid_receptor_2

  • Muscimol
  • Naturally occurring sedative and hallucinogen

    subunit-containing GABAA receptors. It is also a potent GABAA-ρ receptor partial agonist and a weak GABA reuptake inhibitor. The drug is inactive at the GABAB

    Muscimol

    Muscimol

    Muscimol

  • PPAR agonist
  • Drug used for the treatment of symptoms of metabolic syndrome

    well as "pan" agonists acting on all three isoforms. The anti-hypertension drug telmisartan is known to have PPAR γ/δ dual partial agonist activity in vivo

    PPAR agonist

    PPAR agonist

    PPAR_agonist

  • Entactogen
  • Class of psychoactive drugs that produce empathic experiences

    partial agonists that have likewise been implicated as having entactogenic effects. MDMA itself is notable in being a lower-efficacy partial agonist of

    Entactogen

    Entactogen

    Entactogen

  • Head-twitch response
  • Head movement in rodents upon 5-HT2A receptor activation

    full agonist 8-OH-DPAT suppresses the HTR induced by 5-hydroxytryptophan (5-HTP) or DOI, buspirone, a serotonin 5-HT1A receptor partial agonist, has been

    Head-twitch response

    Head-twitch response

    Head-twitch_response

  • Mitragyna speciosa
  • Species of plant

    7-hydroxymitragynine) that bind to opioid receptors, mostly as partial μ-opioid agonists. Kratom can also be subjectively stimulating to some, though this

    Mitragyna speciosa

    Mitragyna speciosa

    Mitragyna_speciosa

  • Serotonin 5-HT2A receptor agonist
  • Drug class

    A serotonin 5-HT2A receptor agonist, or simply 5-HT2A agonist, is a drug which acts as an agonist of the serotonin 5-HT2A receptor. The serotonin 5-HT2A

    Serotonin 5-HT2A receptor agonist

    Serotonin 5-HT2A receptor agonist

    Serotonin_5-HT2A_receptor_agonist

  • Muscle-type nicotinic receptor
  • permeability. Tetraethylammonium (TEA) is a molecule found to be a weak agonist of the muscle‐type nicotinic receptor. Since receptor activation occurs

    Muscle-type nicotinic receptor

    Muscle-type_nicotinic_receptor

  • Buspirone
  • Medication used to treat anxiety disorders

    full agonist at presynaptic 5-HT1A autoreceptors in the dorsal raphe, reducing the firing of serotonin-producing neurons, and as a partial agonist at postsynaptic

    Buspirone

    Buspirone

    Buspirone

  • Imidazenil
  • Benzodiazepine drug

    bretazenil. Imidazenil is a highly potent benzodiazepine receptor partial agonist with an unusual profile of effects, producing some of the effects associated

    Imidazenil

    Imidazenil

    Imidazenil

  • SR-15099
  • Pharmaceutical compound

    been replaced with a bromine atom. The drug is a non-competitive partial biased agonist of the μ-opioid receptor (MOR) similarly to SR-17018. It has similar

    SR-15099

    SR-15099

    SR-15099

  • Antipsychotic
  • Class of medications

    Brexpiprazole (Rexulti) – Partial agonist of the D2 receptor. Successor of aripiprazole. Brilaroxazine – A D2/3/4 and 5-HT1A partial agonist and 5-HT2A/2B/7 antagonist

    Antipsychotic

    Antipsychotic

    Antipsychotic

  • Hypnotic
  • Drug whose use induces sleep

    selective and potent serotonin 5-HT6 receptor weak partial agonist, serotonin 5-HT7 receptor inverse agonist, and serotonin 5-HT1D receptor ligand, with one

    Hypnotic

    Hypnotic

    Hypnotic

  • BP1.4979
  • Pharmaceutical compound

    withdrawal. It is taken orally. The drug acts as a highly potent weak partial agonist of the dopamine D3 receptor (Ki = ~1 nM; EC50Tooltip half-maximal effective

    BP1.4979

    BP1.4979

    BP1.4979

  • Oxytocin receptor agonist
  • Chemical compound

    An oxytocin receptor agonist is a compound that acts as an agonist of the oxytocin receptor. They include peptides like oxytocin and carbetocin and small-molecules

    Oxytocin receptor agonist

    Oxytocin receptor agonist

    Oxytocin_receptor_agonist

  • Desmethylclozapine
  • Active metabolite of the drug clozapine

    partial agonist at these sites similarly to aripiprazole and bifeprunox. Notably, NDMC has also been shown to act as a potent and efficacious agonist

    Desmethylclozapine

    Desmethylclozapine

    Desmethylclozapine

  • Allosteric modulator
  • Substance that binds to a receptor to change its response to stimuli

    can be complicated. A modulator may function as a partial agonist, meaning it doesn't need the agonist it modulates to yield agonistic effects. Also, modulation

    Allosteric modulator

    Allosteric_modulator

  • 5-HT1A receptor
  • Serotonin receptor protein distributed in the cerebrum and raphe nucleus

    atypical antipsychotics like lurasidone and aripiprazole are also partial agonists at the 5-HT1A receptor and are sometimes used in low doses as augmentations

    5-HT1A receptor

    5-HT1A receptor

    5-HT1A_receptor

  • Volume of distribution
  • Theoretical drug measure in pharmacology

    (biochemistry) Excitatory Agonist Endogenous agonist Irreversible agonist Partial agonist Superagonist Physiological agonist Inhibitory Antagonist Competitive

    Volume of distribution

    Volume_of_distribution

  • Area under the curve (pharmacokinetics)
  • Integral of drug concentration in blood plasma over time

    (biochemistry) Excitatory Agonist Endogenous agonist Irreversible agonist Partial agonist Superagonist Physiological agonist Inhibitory Antagonist Competitive

    Area under the curve (pharmacokinetics)

    Area_under_the_curve_(pharmacokinetics)

  • Fenoldopam
  • Antihypertensive agent

    synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist. Fenoldopam is used as an antihypertensive agent. It was approved by

    Fenoldopam

    Fenoldopam

    Fenoldopam

  • Beta-adrenergic agonist
  • Medications that relax muscles of the airways

    Beta adrenergic agonists or beta agonists are medications that relax muscles of the airways, causing widening of the airways and resulting in easier breathing

    Beta-adrenergic agonist

    Beta-adrenergic agonist

    Beta-adrenergic_agonist

  • Dopamine receptor D4
  • Protein-coding gene in the species Homo sapiens

    316: partial agonist, > 8600-fold selective over other dopamine receptor subtypes FAUC 299: partial agonist F-15063: antipsychotic with partial D4 agonism

    Dopamine receptor D4

    Dopamine receptor D4

    Dopamine_receptor_D4

  • Trip killer
  • Drug that blocks hallucinogen effects

    pizotifen, ritanserin, and seganserin, among others. Non-hallucinogenic partial agonists of the serotonin 5-HT2A receptor with sufficiently low intrinsic activity

    Trip killer

    Trip killer

    Trip_killer

  • Long-acting beta-adrenoceptor agonist
  • Drug prescribed for asthma patients

    Long-acting β adrenoceptor agonists (LABAs) are beta-adrenergic agonists usually prescribed for moderate-to-severe persistent asthma and chronic obstructive

    Long-acting beta-adrenoceptor agonist

    Long-acting beta-adrenoceptor agonist

    Long-acting_beta-adrenoceptor_agonist

  • Psychedelic drug
  • Hallucinogenic class of psychoactive drug

    hallucinogenic effects. Full agonists and partial agonists above this threshold are psychedelic 5-HT2A receptor agonists, whereas partial agonists below this threshold

    Psychedelic drug

    Psychedelic drug

    Psychedelic_drug

  • YK-11
  • Steroid drug

    selective androgen receptor modulator (SARM). It is a gene-selective partial agonist of the androgen receptor (AR) and does not induce the physical interaction

    YK-11

    YK-11

    YK-11

  • Cycloserine/lurasidone
  • Combination drug

    Cyclurad, is a combination formulation of the antibiotic D-cycloserine, a partial agonist of the glycine site of the NMDA receptor, and lurasidone, an atypical

    Cycloserine/lurasidone

    Cycloserine/lurasidone

  • List of psychoactive plants
  • List of plant species with reported psychoactive properties

    ; Farnsworth, N. (2005). "Valerian extract and valerenic acid are partial agonists of the 5-HT receptor in vitro". Molecular Brain Research. 138 (2):

    List of psychoactive plants

    List of psychoactive plants

    List_of_psychoactive_plants

  • NMDA receptor antagonist
  • Class of anesthetics

    glycine binding site: Rapastinel (GLYX-13) (weak partial agonist; IA = ~20%). NRX-1074 (weak partial agonist). 7-Chlorokynurenic acid. 4-Chlorokynurenine

    NMDA receptor antagonist

    NMDA receptor antagonist

    NMDA_receptor_antagonist

  • Adrenergic agonist
  • Drug that stimulates a response from the adrenergic receptors

    An adrenergic agonist is a drug that stimulates a response from the adrenergic receptors. The five main categories of adrenergic receptors are: α1, α2

    Adrenergic agonist

    Adrenergic_agonist

  • Mitragynine
  • Opioid analgesic compound

    its use to potentially manage symptoms of opioid withdrawal. It is a partial agonist of the μ-opioid receptors; and as such can produce effects similar

    Mitragynine

    Mitragynine

    Mitragynine

  • Pramipexole
  • Dopamine agonist medication

    together with levodopa. It is taken by mouth. Pramipexole is a dopamine agonist of the non-ergoline class. Pramipexole was approved for medical use in

    Pramipexole

    Pramipexole

    Pramipexole

  • Imepitoin
  • Anti-convulsant medicine used to treat seizures in dogs

    clonazepam) partial agonist of the benzodiazepine site of the GABAA receptor (up to 12–21% of the maximal potentiation of diazepam, a full agonist of this

    Imepitoin

    Imepitoin

    Imepitoin

  • Reverse pharmacology
  • Drug discovery by identifying protein targets

    (biochemistry) Excitatory Agonist Endogenous agonist Irreversible agonist Partial agonist Superagonist Physiological agonist Inhibitory Antagonist Competitive

    Reverse pharmacology

    Reverse pharmacology

    Reverse_pharmacology

  • RO5263397
  • TAAR1 agonist

    or RO-5263397, is a trace amine-associated receptor 1 (TAAR1) partial or full agonist which is used in scientific research. It is the most well-studied

    RO5263397

    RO5263397

    RO5263397

  • Antidepressant
  • Class of medication used to treat depression and other conditions

    well and acts as an SRI and 5-HT1A receptor partial agonist. An alternative term is serotonin partial agonist/reuptake inhibitor (SPARI), which can be applied

    Antidepressant

    Antidepressant

    Antidepressant

  • Pharmacology
  • Science of drugs and medications and their effects

    agonists, partial agonists or antagonists at specific receptors in the body. Agonists bind to receptors and produce a biological response, a partial agonist

    Pharmacology

    Pharmacology

    Pharmacology

  • Beta2-adrenergic agonist
  • Compounds that bind to and activate adrenergic beta-2 receptors

    Beta2-adrenergic agonists, also known as adrenergic β2 receptor agonists, are a class of drugs that act on the β2 adrenergic receptor. Like other β adrenergic

    Beta2-adrenergic agonist

    Beta2-adrenergic agonist

    Beta2-adrenergic_agonist

  • Diprenorphine
  • Chemical compound

    under the brand name Revivon, is a non-selective, high-affinity, weak partial agonist of the μ- (MOR), κ- (KOR), and δ-opioid receptor (DOR) (with equal

    Diprenorphine

    Diprenorphine

    Diprenorphine

  • Pagoclone
  • Chemical compound

    α1, α2, α3 or α5 subunit. It is a partial agonist at α1-, α2- and α5-containing GABAA receptors and a full agonist at receptors containing an α3 subunit

    Pagoclone

    Pagoclone

    Pagoclone

  • Piperidine-4-sulfonic acid
  • Pharmaceutical compound

    γ-aminobutyric acid (GABA). The drug is a potent and selective GABAA receptor partial agonist. It shows functional selectivity at GABAA receptors of different α

    Piperidine-4-sulfonic acid

    Piperidine-4-sulfonic acid

    Piperidine-4-sulfonic_acid

  • Tasipimidine
  • Pharmaceutical compound

    affinity for α1-adrenergic receptors, where it appears to act as a partial agonist. Tasipimidine produces anxiolytic, sedative, hypolocomotor, hypotensive

    Tasipimidine

    Tasipimidine

    Tasipimidine

  • List of miscellaneous 5-HT2A receptor agonists
  • agonism and psychedelic-like effects have been reported. 5-HT2A receptor agonist Partial lysergamide DPCPX LY-341,495 Robalzotan WAY-100635 UH-301 Head-twitch

    List of miscellaneous 5-HT2A receptor agonists

    List of miscellaneous 5-HT2A receptor agonists

    List_of_miscellaneous_5-HT2A_receptor_agonists

  • Bromocriptine
  • Dopamine agonist medication

    autoreceptor locatations) relative to the D2L form, sufficiently low partial agonist activity (i.e. where a molecule binding to a receptor induces limited

    Bromocriptine

    Bromocriptine

    Bromocriptine

  • Raphe nuclei
  • Moderate-size cluster of nuclei found in brain stem

    decrease the release of serotonin. The anxiolytic drug Buspirone acts as partial agonist against these receptors. Selective serotonin reuptake inhibitor (SSRI)

    Raphe nuclei

    Raphe nuclei

    Raphe_nuclei

  • Imidazoleacetic acid
  • Pharmaceutical compound

    as a relatively potent GABAA receptor partial agonist and GABAA-ρ receptor antagonist or weak partial agonist. It shows varying activational efficacies

    Imidazoleacetic acid

    Imidazoleacetic acid

    Imidazoleacetic_acid

  • AC-262,536
  • Chemical compound

    isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5 nM, and no significant affinity

    AC-262,536

    AC-262,536

    AC-262,536

  • Naltrexone
  • Medication

    appears to become an inverse agonist of the MOR. Conversely, the naltrexone remains a neutral antagonist (or weak partial agonist) of the KOR and DOR. In contrast

    Naltrexone

    Naltrexone

    Naltrexone

Searches for online references containing PARTIAL AGONIST

PARTIAL AGONIST

Search references containing PARTIAL AGONIST

PARTIAL AGONIST

Search queries for Facebook and twitter posts, hashtags with PARTIAL AGONIST

PARTIAL AGONIST

Follow users with usernames @PARTIAL AGONIST or posting hashtags containing #PARTIAL AGONIST

PARTIAL AGONIST

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with PARTIAL AGONIST

PARTIAL AGONIST

Top search, Social media, medium, facebook & news articles containing PARTIAL AGONIST

PARTIAL AGONIST

Searches for Acronyms & meanings containing PARTIAL AGONIST

PARTIAL AGONIST

Searches, Indeed job searches and job offers containing PARTIAL AGONIST

Other words and meanings similar to

PARTIAL AGONIST

Search in online dictionary sources & meanings containing PARTIAL AGONIST

PARTIAL AGONIST